Shaolin Capital Management’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Shaolin Capital Management’s Portfolio LVACW Stock Details LVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-283,700	Closed	-$21K	–	1030
2023 Q1	$21K	Buy	283,700 +33,700	+13%	+$1.84K	﹤0.01%	554
2022 Q4	$1K	Hold	250,000	–	–	﹤0.01%	789
2022 Q3	$20K	Hold	250,000	–	–	﹤0.01%	724
2022 Q2	$28K	Hold	250,000	–	–	﹤0.01%	782
2022 Q1	$87K	Buy	+250,000	New	+$101K	﹤0.01%	678

Shaolin Capital Management's LVACW Position: Q2 2023 in Review

Shaolin Capital Management sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 283,700 shares — an estimated $21K sold.

Shaolin Capital Management first reported a position in LVACW in Q1 2022 and held it in 5 quarters. The position peaked at $87K in Q1 2022. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

Shaolin Capital Management reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
Shaolin Capital Management sold 283,700 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $21K.
Shaolin Capital Management first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q1 2022 and held it in 5 quarters.
Shaolin Capital Management's LAVA Medtech Acquisition Corp. Warrants position peaked at $87K in Q1 2022.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Shaolin Capital Management's 13F filing for Q2 2023, filed 15 Aug 2023.